Triple
T5481690
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | COVID-19 vaccines |
E123479
|
entity |
| Predicate | hasType |
P0
|
FINISHED |
| Object |
mRNA vaccine
An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
|
E523135
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: mRNA vaccine | Statement: [COVID-19 vaccines, hasType, mRNA vaccine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: mRNA vaccine Context triple: [COVID-19 vaccines, hasType, mRNA vaccine]
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
COVID-19 vaccines
COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
-
C.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
D.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: mRNA vaccine Triple: [COVID-19 vaccines, hasType, mRNA vaccine]
Generated description
An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: mRNA vaccine Target entity description: An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
COVID-19 vaccines
COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
-
C.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
D.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd4648883481909e9775d43300c5fa |
completed | March 20, 2026, 1:06 p.m. |
| NER | Named-entity recognition | batch_69bd924a2eb08190b759b23a6eab5e0a |
completed | March 20, 2026, 6:30 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bf48a2880c8190ad76cf8c3862aede |
completed | March 22, 2026, 1:40 a.m. |
| NEDg | Description generation | batch_69bf4a95375881909ba730ad108eee8b |
completed | March 22, 2026, 1:49 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69bf4afb47a88190a66de6b6c7d5c241 |
completed | March 22, 2026, 1:50 a.m. |
Created at: March 20, 2026, 2:09 p.m.